Journal Thoracic Oncology

Abstracts Journal of Thoracic Oncology • Volume 12 Issue S1 January 2017
DISCLOSURE SUMMARY
As a sponsor accredited by the Accreditation Council for Continuing Medical Education, the International Association for the Study of Lung Cancer (IASLC) must
insure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All speakers/contributors participating in a sponsored
activity are expected to disclose to the accredited provider any significant financial interest or other relationship(s) involving themselves or their spouse/partner
within the last 12 months with any proprietary entity producing health care goods or services related to the content of the activity. The intent of this disclosure is
not to prevent a speaker with a significant financial or other relationship from making the presentation, but rather to identify and resolve any conflicts of interest
that may control the content of the activity. It is also intended that any potential conflict be identified openly so that the listeners have a full disclosure of the facts
and may form their own judgments about the presentation. It remains for the audience to determine whether the speaker’s interests or relationships may influence
the presentation with regard to exposition or conclusion. All other faculty/contributors have reported no commercial affiliation associated with this conference or
intent to reference off-label/unapproved uses of products or devices in their presentations.
FIRST NAME
LAST NAME
NATURE OF RELEVANT
FINANCIAL RELATIONSHIP
Nivedita Aanur Full-time/part-time Employee BMS
Nivedita Aanur Stock Shareholder (directly purchased) BMS
A Abbattista Full-time/part-time Employee Pfizer
A Abbattista Stock Shareholder (directly purchased) Pfizer
NAME OF COMPANY(S)
Chihiro Abe Full-time/part-time Employee Daiichi Sankyo. Co., Ltd.
Amy Abernethy Consultant Roche/Genentech, BMS, Helsinn
Amy Abernethy Full-time/part-time Employee Flatiron Health (full time)
Ellias Abreu Lima Honoraria Astrazeneca
Nacer Abrouk Consultant EpicentRx, Inc
Brenda Acevedo Grants/Research Support
Brenda Acevedo Other (explain): Travel: Vascular Biogenics
Joachim Aerts Consultant Amphera bv
Joachim Aerts Consultant Lilly
Joachim Aerts Grants/Research Support Amphera bv
Joachim Aerts Other (explain): Amphera bv
Daniel Afar Full-time/part-time Employee AbbVie
Daniel Afar Stock Shareholder (directly purchased) AbbVie, may own stock
Suresh Agarwal Full-time/part-time Employee Roche
Charu Aggarwal Consultant Genentech, Roche
Acerta Pharma, Bristol-Myers Squibb, Nektar, Celldex, Sanofi,
Vascular Biogenics
Tanya Ahmad Grants/Research Support AstraZeneca, Boehringer Ingelheim, Eli-Lilly, Pfizer
Tanya Ahmad Honoraria Boehringer Ingelheim, Neo Oncology
Tanya Ahmad Other (explain): Boehringer Ingelheim, MSD, Pfizer, Pierre Fabre
Myung-Ju Ahn Consultant AstraZeneca, BMS, Boehringer Ingelheim, MSD, Novartis
Hiroaki Akamatsu Honoraria
AstraZeneca, Eli Lilly, Chugai Pharmaceuticals, Boehringer
Ingelheim, Merck, Pfizer, Ono Pharmaceuticals, Taiho
Pharmaceuticals, Novartis
Mikhail Akimov Full-time/part-time Employee Novartis
Mikhail Akimov Stock Shareholder (directly purchased) Novartis
Mahmood Alam Full-time/part-time Employee Pfizer
Jordi Alcaraz Grants/Research Support Boheringer-Ingelheim
Ekaterine Alexandris Full-time/part-time Employee Eli Lilly and Company
Ekaterine Alexandris Stock Shareholder (directly purchased) Eli Lilly and Company
Siraj Ali Full-time/part-time Employee Foundation Medicine
Ash Alizadeh Consultant Roche
Brian Allen Full-time/part-time Employee Myriad Genetics, Inc.
Brian Allen Stock Shareholder (directly purchased) Myriad Genetics, Inc.
Jared Allen Full-time/part-time Employee Oncimmune Ltd
Justin Allen Full-time/part-time Employee Foundation Medicine
Justin Allen Stock Shareholder (directly purchased) Foundation Medicine
James Allison Consultant Bristol-Myers Squibb, Amgen, GlaxoSmithKline
S810 Journal of Thoracic Oncology • Volume 12 Issue S1 January 2017